Invitae Corp.
(NYSE : NVTA)

( )
NVTA PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Services » Medical Or Nursing Services
symbolcompany%chnglast%shortavg$volume
DVADaVita HealthCare Partners Inc.
2.78%61.002.0%$155.19m
EVHCEnvision Healthcare Holdings, Inc.
-2.17%44.158.0%$97.11m
MDMEDNAX, Inc.
-0.05%44.4910.1%$61.66m
ACHCAcadia Healthcare Company, Inc.
0.54%44.6927.5%$38.09m
AMEDAmedisys, Inc.
-1.07%49.7311.0%$17.36m
CHEChemed Corporation
-0.87%208.3710.1%$16.43m
LHCGLHC Group, Inc.
0.25%67.835.0%$9.66m
PMCPharMerica Corporation
-0.17%29.152.4%$7.64m
FMSFresenius Medical Care AG & Co. KGaA Sponsored ADR
-0.12%48.830.1%$7.58m
AFAMAlmost Family, Inc.
-1.37%46.903.4%$5.29m
USPHU.S. Physical Therapy, Inc.
-0.15%65.954.8%$4.18m
ENSGEnsign Group, Inc.
-0.35%22.946.1%$3.15m
RDNTRadNet, Inc.
0.00%11.150.5%$3.01m
NEONeoGenomics, Inc.
-1.47%8.717.9%$2.83m
COChina Cord Blood Corporation
-1.56%10.750.3%$2.48m

Company Profile

Invitae Corp. engages in the provision of genetic information into mainstream medical practice. It provides diagnostic service comprising approximately 1,500 genes for a variety of genetic disorders associated with oncology, cardiology, neurology, pediatrics, and whole exome analysis service. The company has created a genome network to connect patients, clinicians, advocacy organizations, researchers, and therapeutic developers to accelerate the understanding, diagnosis, and treatment of hereditary disease. Invitae was founded by Randal W. Scott and Sean E. George on January 13, 2010 and is headquartered in San Francisco, CA.